Aylward B, Johnson C, Perry F, Whelan R, Arsenault R
Front Physiol. 2024; 15:1473202.
PMID: 39552722
PMC: 11565619.
DOI: 10.3389/fphys.2024.1473202.
Wen Y, He H, Ma Y, Bao D, Cai L, Wang H
Life Sci Alliance. 2024; 8(2).
PMID: 39537342
PMC: 11561260.
DOI: 10.26508/lsa.202402971.
Fadaghi S, Mahmoodi M, Derakhshani A, Sedghy F, Ranjkesh M, Behzadi A
Heliyon. 2024; 10(16):e35667.
PMID: 39220890
PMC: 11365297.
DOI: 10.1016/j.heliyon.2024.e35667.
Fink F, Hopfl R, Witsch-Baumgartner M, Kropshofer G, Martin S, Fink V
Front Immunol. 2024; 15:1430938.
PMID: 39114664
PMC: 11303233.
DOI: 10.3389/fimmu.2024.1430938.
Frigault M, Graham C, Berger T, Ritchey J, Horick N, El-Jawahri A
Blood. 2024; 144(11):1153-1167.
PMID: 38781564
PMC: 11830985.
DOI: 10.1182/blood.2024024104.
A Review of the Evidence for Tryptophan and the Kynurenine Pathway as a Regulator of Stem Cell Niches in Health and Disease.
Summers B, Broome S, Pang T, Mundell H, Koh Belic N, Tom N
Int J Tryptophan Res. 2024; 17:11786469241248287.
PMID: 38757094
PMC: 11097742.
DOI: 10.1177/11786469241248287.
Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases.
Velikic G, Maric D, Maric D, Supic G, Puletic M, Dulic O
Int J Mol Sci. 2024; 25(2).
PMID: 38256066
PMC: 10816024.
DOI: 10.3390/ijms25020993.
Recognizing, defining, and managing CAR-T hematologic toxicities.
Rejeski K, Subklewe M, Locke F
Hematology Am Soc Hematol Educ Program. 2023; 2023(1):198-208.
PMID: 38066881
PMC: 10727074.
DOI: 10.1182/hematology.2023000472.
Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study.
Mayito J, Meya D, Miriam A, Dhikusooka F, Rhein J, Sekaggya-Wiltshire C
PLoS One. 2023; 18(11):e0291834.
PMID: 38033005
PMC: 10688757.
DOI: 10.1371/journal.pone.0291834.
CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma.
Ostojska M, Nowak E, Twardowska J, Lejman M, Zawitkowska J
J Pers Med. 2023; 13(11).
PMID: 38003910
PMC: 10672004.
DOI: 10.3390/jpm13111595.
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.
Rejeski K, Perez A, Iacoboni G, Blumenberg V, Bucklein V, Volkl S
Sci Adv. 2023; 9(38):eadg3919.
PMID: 37738350
PMC: 10516499.
DOI: 10.1126/sciadv.adg3919.
Depletion of Bone Marrow Hematopoietic Cells in Ebolavirus-Infected Rhesus Macaques: A Possible Cause of Hematologic Abnormalities in Ebolavirus Disease.
Liu D, Pahar B, Perry D, Xu H, Cooper T, Huzella L
Am J Pathol. 2023; 193(12):2031-2046.
PMID: 37689386
PMC: 10699128.
DOI: 10.1016/j.ajpath.2023.08.010.
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.
Strati P, Li X, Deng Q, Marques-Piubelli M, Henderson J, Watson G
Cell Rep Med. 2023; 4(8):101158.
PMID: 37586321
PMC: 10439270.
DOI: 10.1016/j.xcrm.2023.101158.
Infection with hypervirulent triggers emergency myelopoiesis but not trained immunity.
Maceiras A, Silverio D, Goncalves R, Cardoso M, Saraiva M
Front Immunol. 2023; 14:1211404.
PMID: 37383236
PMC: 10296772.
DOI: 10.3389/fimmu.2023.1211404.
Both maternal IFNγ exposure and acute prenatal infection with Toxoplasma gondii activate fetal hematopoietic stem cells.
Lopez D, Otsuka K, Apostol A, Posada J, Sanchez-Arcila J, Jensen K
EMBO J. 2023; 42(14):e112693.
PMID: 37259639
PMC: 10350822.
DOI: 10.15252/embj.2022112693.
The rs361525 and rs2430561 polymorphisms are associated with liver cirrhosis risk: a comprehensive meta-analysis.
Zheng M, Li J, Fang W, Luo L, Ding R, Zeng H
Front Immunol. 2023; 14:1129767.
PMID: 37122734
PMC: 10140545.
DOI: 10.3389/fimmu.2023.1129767.
The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms.
Balandran J, Lasry A, Aifantis I
Blood Cancer Discov. 2023; 4(4):254-266.
PMID: 37052531
PMC: 10320626.
DOI: 10.1158/2643-3230.BCD-22-0176.
Management of adverse events in young adults and children with acute B-cell lymphoblastic leukemia receiving anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.
Yoo J
Blood Res. 2023; 58(S1):S20-S28.
PMID: 36891576
PMC: 10133856.
DOI: 10.5045/br.2023.2023026.
How I treat cytopenias after CAR T-cell therapy.
Jain T, Olson T, Locke F
Blood. 2023; 141(20):2460-2469.
PMID: 36800563
PMC: 10646792.
DOI: 10.1182/blood.2022017415.
Age-related decline in LEPR hematopoietic stem cell function.
Trinh T, Ropa J, Cooper S, Aljoufi A, Sinn A, Capitano M
Leukemia. 2023; 37(3):712-716.
PMID: 36650272
PMC: 9991916.
DOI: 10.1038/s41375-023-01815-1.